Exelon Corporation (EXC)
Live price chart, market sentiment, and community perspectives for Exelon Corporation (NASDAQ: EXC).
Live price chart, market sentiment, and community perspectives for Exelon Corporation (NASDAQ: EXC).
On our desk, the recent slashing of Exelon's data center pipeline—dropping from 18 GW down to 11 GW—is a clear inflection point that forces a re-evaluation of their near-term growth narrative. While Q2 revenue rose 10% to $5.97 billion and management reaffirmed 2026 adjusted operating EPS guidance of $2.81 to $2.91, the market clearly punished the stock following the July 30 drop. Consumers pushing back against new developments over utility bill concerns introduces a tangible regulatory and social friction that didn't exist previously. With 16 'Holds' out of 22 analysts and a consensus rating stuck firmly in neutral, sentiment remains defensive rather than opportunistic.
Watching the macro performance, EXC continues to lag behind both the broader SandP 500 and the utilities sector ETF (XLU) over the 52-week window. The stock has returned roughly 3% compared to the SandP 500's 16.9% surge, highlighting a distinct lack of capital velocity into the name. Even though the company maintains a stable $41 billion five-year capital plan after weeding out speculative projects, the reduced total future pipeline through 2027 down to 25 GW from 43 GW signals decelerating momentum in AI and data center tailwinds that investors were initially pricing in.
When evaluating quantitative models for EXC, analysts must account for the strict alignment between reported earnings and consensus estimates—having beaten or met expectations in each of the last four quarters. However, basic valuation metrics indicate that revenue growth is expected to underperform the wider industry. When modeling upside, note that the mean price target sits around $49.95, representing a modest 9.6% premium from current levels near $45.82, framed by a tight bull-bear band spanning from a bearish $41.00 to a bullish $58.00.
Explore plasma cleansing, somatic organ swaps, and BCI.